PHIO

Phio Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth 7/10
  • Momentum 1/10
Phio Pharmaceuticals sales and earnings growth
PHIO Growth
Good
  • Revenue Y/Y 0.00%
  • EPS Y/Y 80.22%
  • FCF Y/Y 10.20%
Phio Pharmaceuticals gross and profit margin trends
PHIO Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC 960.20%
Phio Pharmaceuticals net debt vs free cash flow
PHIO Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage NA

Phio Pharmaceuticals stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗